TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery

Clinical trial NCT04197687 · UNKNOWN

Trial details

NCT number: NCT04197687
Sponsor: Academic and Community Cancer Research United
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Adenocarcinoma Stage II Breast Cancer AJCC v6 and v7 Stage IIA Breast Cancer AJCC v6 and v7 Stage IIB Breast Cancer AJCC v6 and v7 Stage III Breast Cancer AJCC v7 Stage IIIA Breast Cancer AJCC v7 Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7

Start date: 2020-02-20
Primary completion: 2025-01-15
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.